Analyst Ratings for Solid Biosciences (SLDB)
SLDB Rating Summary
SLDB Price Target Summary
- Highest: $26.00 (Cantor Fitzgerald)
- Lowest: $9.00 (Barclays)
- Average: $18.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$18.00 (+225.5%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
Rating Score: 8.2 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/14/2026 | UBS | N/A | New Coverage | Buy (N/A) |
20.00 (N/A) |
5.82 (5.53) |
-4.98% | Details |
| 9/16/2026 | RBC Capital | N/A | New Coverage | Outperform (N/A) |
18.00 (N/A) |
8.37 (5.53) |
-33.93% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||



